Is ownership actually relevant? Pharma M&A Briefing

Is Ownership Actually Relevant?

As Pfizer and AstraZeneca are called before a British parliamentary committee to discuss Pfizer’s potential takeover bid, the question arises of whether ownership is relevant in the Pharma M&A world? ¬† In the next chapter of the Pfizer AstraZeneca saga, the government has waded in to call both companies to a parliamentary committee, to discuss the situation. Whilst AstraZeneca has …

Pharma M&A Briefing: AstraZeneca rejects Pfizer

AstraZeneca rejects Pfizer’s new proposal

Pfizer increased its offer to AstraZeneca to ¬£50 a share today, putting pressure on the UK pharmaceuticals group to open discussions, in what could lead to a deal that would create the world’s largest drugs company. However within hours¬†AstraZeneca has once again refused to come to the table. In a statement released today, AstraZeneca have stated that the terms outlined …